| Literature DB >> 1541934 |
H Murakami1, K Nemoto, S Miyawaki, S Shinonome, E Nogiwa, S Shimano, S Sato, M Omine, T Naruse, J Tsuchiya.
Abstract
Of 130 Japanese patients with symptomatic multiple myeloma who were treated between 1970 and 1989, nine (6.9%) patients survived for more than 10 years. Younger age, low and intermediate tumour mass, chemotherapy with cyclophosphamide, the disappearance of myeloma protein, and a positive response to retreatment were correlated with long-term survival.Entities:
Mesh：
Year: 1992 PMID： 1541934 DOI： 10.1111/j.1365-2796.1992.tb00513.x
Source DB: PubMed Journal: J Intern Med ISSN： 0954-6820 Impact factor: 8.989